Absenteeism Savings
Hours of work no longer lost to mental health-related absence. Recovered against employee hourly cost.
Built on the published EAP industry ROI methodology (Attridge, Sharar & Lennox, 2010-2025) and validated against international clinical thresholds. Real deployment, real data, real numbers.
12-MONTH DEPLOYMENT
4.2×
RETURN ON INVESTMENT
Recovered
₹91L
Invested
₹22L
WHAT YOU GET BACK
ROI is the headline. These five components are how it is calculated — the EAP industry's published economic framework, mapped to outcomes your CFO, CHRO, and operations leaders will recognise in the workforce data.
Hours of work no longer lost to mental health-related absence. Recovered against employee hourly cost.
Hidden productivity loss recovered as employees regain concentration at work. Typically the largest single component of ROI in India.
Replacement cost savings as employees stop dreading work. Most material in high-tenure roles where replacement costs run highest.
Productivity uplift as the workforce shifts from "less unwell" to "more engaged." The positive-side gain, not just absence of distress.
Mental health treatment costs avoided as employees skip the escalations — severe episodes, hospitalisation, long-term therapy — that come from untreated distress.
This is the Chestnut/Morneau Shepell EAP ROI framework — used by 400+ providers globally, established across two decades of peer-reviewed research (Attridge, Sharar & Lennox, 2010-2025). Each component maps to a specific question in the Workplace Outcome Suite (WOS), the validated 25-item instrument employees actually complete.
Refill Health applies this framework conservatively. Lower-bound published values for every input. The result is an ROI estimate that is harder to challenge upward than downward.
The first three (A, B, C) drive the ROI calculation directly. The fourth (D) captures the upside that traditional EAPs miss — employees who don't just stop being unwell but actually start thriving. The fifth (E) reflects the preventive logic of early clinical intervention — caught early, escalations are avoided.
Methodology note
Detailed component-level math, sensitivity analysis, and India-specific calibration are reviewed line-by-line in the procurement-grade ROI demo. Write to clinical@refillhealth.com to schedule.
WHY THIS WORKS.
The ₹91 lakh in returned economic value didn't appear from engagement theatre or self-reported satisfaction. It appeared because employees with clinically significant depression, anxiety, and burnout achieved measurable improvement against international clinical standards.
↓42% average
PHQ-9 (Depression). Well above the NICE 5-point threshold for clinical significance.
↓52% average
GAD-7 (Anxiety). Well above the NICE 4-point threshold for clinical significance.
Significant ↓
BAT-4 (Burnout). Above the published threshold for meaningful change.
These are not subjective improvement scores. They are reductions measured against the international clinical standard for distinguishing real change from measurement noise. A 1-point reduction on PHQ-9 may be noise. A 5-point reduction is clinical recovery.
Improvement was driven by a coordinated, mixed-modality care system — not a single intervention type: Therapy delivered by RCI-registered clinical psychologists. Coaching delivered by ICF-certified coaches. Self-care tools. Care Navigators. In the SLV deployment, roughly 60% of the cohort received coaching as the primary care channel and 40% received therapy as primary.
Clinical depression and anxiety reduce concentration at work — when they decline, productivity recovers. Workplace distress drives intent to leave — when it declines, attrition risk declines. Improved clinical state means fewer sick days, fewer healthcare escalations, more workforce engagement. The ROI components in Section 2 are not abstractions. They are the financial expression of clinical change.
Cross-reference: The clinical methodology — instruments, supervision, measurement-based care, crisis protocols — is detailed in the Clinical Model page.

WHY YOU CAN TRUST THIS
Refill Health's outcome and ROI claims rest on four pillars of credibility — each one designed to survive the most rigorous procurement review.
The ROI calculation uses the EAP industry's peer-reviewed framework (Attridge, Sharar & Lennox, 2010-2025), the same framework used by 400+ providers worldwide. The math is published; we apply it transparently.
Every clinical outcome is measured using globally validated instruments (PHQ-9, GAD-7, BAT-4, WOS), against the international standard for clinical significance (NICE thresholds). No proxy estimates. No subjective satisfaction scores.
71% engagement against an India EAP industry benchmark of below 5%. Engagement at this scale is what allows clinical and financial outcomes to aggregate to workforce-level numbers — and it is, to our knowledge, the highest deployment-level engagement rate published in the India market.
The published outcome data on this page comes from a single named client deployment — SLV Technologies, the client whose approval we have to publish results publicly. The methodology is the published global standard; the deployment-level numbers are what they measured; forward projections for your workforce require recalibration, which is what the procurement-grade demo is for.
Most workforce mental health vendors prove credibility through "as featured in" logos and award badges. Refill Health proves credibility through methodology, instruments, engagement scale, and transparency.
Logos are marketing. Methodology is what survives a CFO review.
WHAT YOU GET IN PRACTICE.
A Refill Health engagement runs on a quarterly outcome-reporting cadence. Each report combines clinical, productivity, and ROI signals.

Pre-vs-current PHQ-9, GAD-7, BAT-4 distributions against NICE thresholds. Engagement and utilisation rates. Attribution of outcomes to therapy, coaching, and self-care channels.
WOS-derived productivity recovery estimates. Healthcare cost avoidance estimates. Attrition risk reduction signals. Calibrated against your specific workforce, not industry averages.
Crisis-protocol adherence, escalation handling, supervision flags. Aggregated, anonymised, board-ready.
Department- and function-level views (where cohort sizes permit anonymisation). Real-time engagement, outcomes, risk signals — not utilisation sheets.
What's never in any report: Individual employee data is never included. Department-level data appears only when the cohort is large enough to anonymise. Crisis or clinical detail at the individual level flows only to clinical leadership, never to the employer's HR team.
Forward-projected ROI for your workforce: Refill Health's published outcome data is from one named deployment. The ROI projection for your workforce requires calibration — for your headcount, salary distribution, healthcare cost basis, industry-specific attrition dynamics, and engagement assumptions. This is what the procurement-grade ROI demo is built around. In a focused session, our team walks through the methodology applied to your workforce, with sensitivity analysis and a forward-projected ROI range you can defend.
PROOF.
SLV Technologies is the client whose approval we have to publish results publicly. The headline numbers below are the operational proof behind every claim on this page.
CLIENT
SLV Technologies
SCOPE
362 onboarded employees
DURATION
12 months
CARE CHANNELS
Therapy (RCI) + Coaching (ICF) + self-care + Navigators.
ROI
4.2x
DEPRESSION REDUCTION
↓42%
ANXIETY REDUCTION
↓52%
ENGAGEMENT RATE
71%
SESSIONS TO IMPROVEMENT
4.2 avg
CRISIS PROTOCOL ADHERENCE
100%
Honesty Block
We do not cherry-pick data. These results reflect the complete deployment cohort at SLV Technologies, including those who completed only a portion of their care plan. Real-world results are messier than lab trials, but they are more honest.
Method Note
Clinical recovery is defined as a 5-point reduction in PHQ-9 or a 4-point reduction in GAD-7. The results above indicate the weighted average improvement across the entire engaged population.
Refill Health applies the most conservative published assumptions, against a single named deployment, to land at 4.2×. Better instruments. Better engagement. Better workforce. Higher numbers.